A new war is being waged in the networking industry between Cisco and Multiven, with both firms making serious accusations about each other’s practices.
By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.
Multiven yesterday made a public statement accusing the networking giant of using automated cyber scraping software to steal data from its servers.
It claimed more than 53,000 requests were made to its server from IP addresses at Cisco’s headquarters in San Jose, causing a huge slow in its service for customers, as well as capturing what it claimed to be proprietary files.
Multiven CEO Peter Alfred-Adekeye went as far as to accuse Cisco CEO John Chambers of “instigating these thefts”, but said rather than pursuing a civil case, it has called for a public apology and the promise that no Multiven data was used to help Cisco gain a competitive advantage.
“Start-ups and young enterprises are key to turning around the current global economic downturn,” said Alfred-Adekeye. “However, for them to succeed, the law must protect their intellectual property from monopolistic organisations that abuse their dominant positions to stifle competition, innovation and consumer choice for their selfish gain.”
Multiven may be waiting a long time for such an apology to come though.
This morning, Cisco sent Computer Weekly a statement rebuking the claims and accusing Multiven of foul play.
“This is yet another false accusation from Multiven, and we strongly reject this claim,” it read. “The only access that Cisco has ever had to Multiven content is through its website, which is readily available to the general public.”
The spokeswoman then highlighted that Alfred-Adekeye needs to defend himself in the US legal system.
“It’s important to note that Multiven’s CEO is currently under federal indictment in the US for behaviour – including stealing Cisco software in violation of the federal Anti-Hacking Statute – similar to its own accusations.”
Multiven had not updated its statement at the time of publication.